EUVIMEDEUVIMED entdecken
Validierungsstudie

Prolonged administration of letrozole induces polycystic ovary syndrome leading to osteoporosis in rats: model development and validation studies

Zakiya Usmani, Sheeraz Ahmad, Zeba Usmani, Taru Mishra, Abul Kalam Najmi, Saima Amin, Aayeena Altaf, Showkat Rasool Mir

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-03906-5 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Zakiya Usmani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Phyto-Pharmaceutical Drug Research Lab., School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. Hauptthemen laut MEDLINE: Letrozole, Polycystic Ovary Syndrome, Aromatase Inhibitors, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) mainly affects women of reproductive age. Clinical studies suggest a link between PCOS and osteoporosis (OP). Our goal was to explore the correlation between the two. Seventy-two female rats were divided into four groups of 18 each. Control group received vehicle (0.5% solution of carboxymethyl cellulose/day). Rats in treatment groups 2, 3 and 4 received letrozole orally at 0.1, 0.5 or 1.0 mg/kg bodyweight daily, respectively for ten weeks. Their estrous cycle, hormonal and biochemical parameters were observed along with the histological changes in their ovaries and femur bones. Treatment groups were administered metformin (50 mg/kg daily) orally for three weeks after the administration of letrozole was stopped. Letrozole disrupted the estrous cycle and produced ovarian cysts. Its administration elevated luteinizing hormone and testosterone levels, and reduced estradiol and progesterone levels in a dose-dependent manner. Groups 3 and 4 showed increased porosity, thinning of trabeculae and expanded vascular cavities in femur on withdrawal of letrozole. Rats treated with 0.5 mg/kg of letrozole did not show resumption of estrous cycle or normalization of deranged hormonal levels on their own. Metformin administration was successful in regressing the ovarian cysts in these rats. The estrous cycle was also resumed within ten days of metformin administration. However, the ovarian cysts did not regress even with metformin in rats administered with 1.0 mg/kg of letrozole. It was thus concluded that prolonged PCOS induced by 0.5 mg/kg letrozole administration daily for ten weeks may have ultimately led to OP in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LetrozolePolycystic Ovary SyndromeAromatase InhibitorsOsteoporosisNitrilesAnimalsFemaleDisease Models, AnimalEstrous CycleRatsFemurTestosteroneRats, WistarOvaryMetforminDose-Response Relationship, DrugEstradiolProgesteroneLuteinizing Hormone

Stichwörter der Autor:innen

Aromatase inhibitorsBone healthHyperandrogenismInfertilityOvarian cystReproductive health

Substanzen

LetrozoleAromatase InhibitorsTestosteroneMetforminEstradiolProgesteroneLuteinizing HormoneNitriles

Autor:innen und Institutionen

  • Phyto-Pharmaceutical Drug Research Lab., School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. aknajmi@jamiahamdard.ac.in.
  • Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
  • Amity Institute of Biotechnology, Amity University Jaipur, Jaipur, Rajasthan, India.
  • Phyto-Pharmaceutical Drug Research Lab., School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. showkatrmir@gmail.com.
  • Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. showkatrmir@gmail.com.

Zitieren

APA

Usmani, Z., Ahmad, S., Usmani, Z., Mishra, T., Najmi, A. K., Amin, S., Altaf, A., & Mir, S. R. (2025). Prolonged administration of letrozole induces polycystic ovary syndrome leading to osteoporosis in rats: model development and validation studies. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-03906-5

Vancouver

Usmani Z, Ahmad S, Usmani Z, Mishra T, Najmi AK, Amin S, et al. Prolonged administration of letrozole induces polycystic ovary syndrome leading to osteoporosis in rats: model development and validation studies. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-03906-5

BibTeX
@article{Usmani2025,
  author = {Usmani, Zakiya and Ahmad, Sheeraz and Usmani, Zeba and Mishra, Taru and Najmi, Abul Kalam and Amin, Saima and Altaf, Aayeena and Mir, Showkat Rasool},
  title = {Prolonged administration of letrozole induces polycystic ovary syndrome leading to osteoporosis in rats: model development and validation studies},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-03906-5}
}
Kostenlos starten →